Navigation Links
Gen-Probe to Webcast Presentation at 26th Annual JPMorgan Healthcare Conference
Date:1/3/2008

SAN DIEGO, Jan. 2 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the 26th Annual JPMorgan Healthcare Conference on Wednesday, January 9, 2008 at approximately 3:30 p.m. Pacific Time (6:30 p.m. Eastern Time). The presentation is scheduled to be webcast live and may be accessed through a link on the investor information section of Gen-Probe's website at http://www.gen-probe.com. The webcast will be available for 30 days following the event.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statemen
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
2. Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations
3. Gen-Probe to Webcast Presentation at NASDAQ 20th Investor Program
4. Webcast Alert: Kaiser Permanente Residency Program Open House
5. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
6. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
7. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
8. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
9. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
10. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)...w may be too late when it comes to preventing or i...lub, Inc. (Take Off Pounds Sensibly), the nonprofi... (Vocus) November 9, 2009 -- Tomorrow ...roving a diabetes condition, according to TOPS Clu...weight-loss support organization., , ,Diabetes is ...
(Date:11/9/2009)...dy highlights positive influence of sports partici...osemont, IL (Vocus) November 9, 2009 -- As people ...Recent research has highlighted the importance of ...hese issues. However, a new study published in the...idisciplinary Approach reveals that there may be ...
(Date:11/9/2009)...9 Actress Mariska Hargitay and the... on Saturday to raise awareness about the need for...ifornia by building healing and wellness kits for ...d to give one to each of the estimated 600 women c...,s domestic violence shelters. ,, "Our goal is ...
(Date:11/9/2009)... National Ambassador ,, WHITE PLAINS, N.Y., N... Weston, Fla., was born so early and with so many ...hether he would survive -- or if he would ever wal...med March of Dimes 2010 National Ambassador. ,...t minutes of motherhood and I was completely devas...
Breaking Medicine News(10 mins):Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3
...s,International, Inc. (NYSE: WTW ) will release i...YSE close on Thursday, July 31, 2008., The Compan...t at 5:00,p.m. ET. During the conference call, Dav...s from the investment community., Live audio of t...
...l Combat Veterans, WASHINGTON, July 9 Combat vet...er assistance in 39 additional,communities across ...rs,(VA) will develop Vet Centers by fall 2009., "...terans Affairs. "I,m pleased we can expand access ...
...pitals, WASHINGTON, July 9 CNN reported this mor... System (Corpus Christi TX),received overdoses of ...DT,one of the babies has died; another is in criti...Group,s number one,safety measure that it urges al...
... of new lines may be done without destroying embry...- Scientists say they have finally succeeded in de... development stage of a blastomere, or a 4-cell st...& Embryology annual conference in Barcelona, m...
...tion of 50 years of publishing groundbreaking rese...3 papers that highlight pivotal research and signi...rgonomics (HF/E). The entire online issue is avail...ystems, environments, tools, and products. As note...
...8 Led by Anna Catriona Phillips of the University...to a hepatitis A vaccine in young healthy adults a... vaccination in older community-based adults. , ...ession (10 am to 12 pm) or early evening session (...
Other Medicine News:Health News:Weight Watchers Announces Second Quarter 2008 Earnings Conference Call 2Health News:VA Vet Centers Coming to 39 Communities 2Health News:Statement of the Leapfrog Group on Hospital Overdose of Up to 17 Babies at CHRISTUS Spohn 2Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Human Factors Journal celebrates 50 years 2
(Date:11/9/2009)...tCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: AR...d quarter ended September 30, 2009. ,, Arena re...olders in the third quarter of 2009 of $34.8 milli...ocable to common stockholders in the third quarter... a net loss allocable to common stockholders in th...
(Date:11/9/2009)...riGene Technologies, Inc. today announced Royal In...RIFY Tagged Antigen(TM) (Over-expression Lysates) ...s funded by the Knut and Alice Wallenberg Foundati...tematically using Antibody-Based Proteomics. "Gene...high throughput manner is critical for the success...
(Date:11/9/2009)...- Asthmatx, Inc. presented the results of a series...fety of bronchial thermoplasty delivered by the Al...impact allergy practices, this past weekend in a p...ollege of Allergy, Asthma and Immunology (ACAAI), ...re Could Bronchial Thermoplasty (BT) Fit Into Your...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 1AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 1Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 3Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 4
... Lixte,Biotechnology Holdings, Inc. (OTC Bulletin ...rom each of two different types of drugs being,dev...f brain cancers have,activity against human pancre...h, President and CEO of Lixte, said, "Lixte previo... different classes of,pharmacologic agents have si...
...eting with the FDA for the Fabry Program and Init...lights for the Quar...(Nasdaq: FOLD ), a biopharmaceutical company deve...logical chaperones for the treatment of human,gene...r the second quarter,of 2008. On a reported basis ...
Other Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 3Amicus Therapeutics Announces Second Quarter 2008 Financial Results 4Amicus Therapeutics Announces Second Quarter 2008 Financial Results 5Amicus Therapeutics Announces Second Quarter 2008 Financial Results 6Amicus Therapeutics Announces Second Quarter 2008 Financial Results 7Amicus Therapeutics Announces Second Quarter 2008 Financial Results 8Amicus Therapeutics Announces Second Quarter 2008 Financial Results 9Amicus Therapeutics Announces Second Quarter 2008 Financial Results 10Amicus Therapeutics Announces Second Quarter 2008 Financial Results 11Amicus Therapeutics Announces Second Quarter 2008 Financial Results 12
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: